Page 62 - TD-4-3

Tumor Discovery Prognostication in palliative cancer care

and 2021/212312/REK midt). In accordance with the performance status and symptom scores for patients with
Norwegian health care legislation, explicit informed cancer during the last six months of life. J Clin Oncol.
consent was not needed. 2011;29(9):1151-1158.
doi: 10.1200/JCO.2010.30.7173
Consent for publication
9. Haupt EC, Sharma I, Nguyen HQ. Symptom burden and
On specific request, The Regional Committee for Medical survival in patients receiving outpatient and home-based
Research Ethics, Health Region Central Norway (REK) palliative care. J Palliat Med. 2023;26(6):843-848.
stated that addressing patients or relatives of deceased doi: 10.1089/jpm.2022.0267
patients for consent for publication would constitute
a burden without benefit, as the presented data are 10. Løhre ET, Klepstad P, Bennett MI, et al. From “breakthrough”
completely anonymized and by no means suitable for to “episodic” cancer pain? A European association for
identifying individual patients. Thus, a request of consent palliative care research network expert Delphi survey toward
for publication was not recommended or needed. a common terminology and classification of transient
cancer pain exacerbations. J Pain Symptom Manage.
Availability of data 2016;51(6):1013-1019.
doi: 10.1016/j.jpainsymman.2015.12.329
All the primary data and all the analyzes are stored at
an institutional server and can be obtained from the 11. Karnofsky DA, Abelmann WH, Craver LF, Burchenal JH.
corresponding author at reasonable request. The use of the nitrogen mustards in the palliative treatment
of carcinoma - with particular reference to bronchogenic
References carcinoma. Cancer. 1948;1(4):634-656.

1. Parkes CM. Accuracy of predictions of survival in later doi: 10.1002/1097-0142(194811)1:4<634:AID-
stages of cancer. Br Med J. 1972;2(5804):29-31. CNCR2820010410>3.0.CO;2-L
doi: 10.1136/bmj.2.5804.29 12. Oken MM, Creech RH, Tormey DC, et al. Toxicity and
response criteria of the Eastern cooperative oncology group.
2. Glare PA, Sinclair CT. Palliative medicine review: Am J Clin Oncol. 1982;5(6):649-655.
Prognostication. J Palliat Med. 2008;11(1):84-103.
13. Jang RW, Caraiscos VB, Swami N, et al. Simple prognostic
doi: 10.1089/jpm.2008.9992 model for patients with advanced cancer based on
3. Hui D, Paiva CE, Del Fabbro EG, et al. Prognostication in performance status. J Oncol Pract. 2014;10(5):e335-e341.
advanced cancer: Update and directions for future research. doi: 10.1200/JOP.2014.001457
Support Care Cancer. 2019;27(6):1973-1984.
14. Rocha BMM, Dolan RD, Paiva CE, et al. Inflammation
doi: 10.1007/s00520-019-04727-y and performance status: The cornerstones of prognosis
4. Hui D. Prognostication of survival in patients with advanced in advanced cancer. J Pain Symptom Manage.
cancer: Predicting the unpredictable? Cancer Control. 2023;65(4):348-357.
2015;22(4):489-497. doi: 10.1016/j.jpainsymman.2022.11.021
doi: 10.1177/107327481502200415 15. Evans C, McCarthy M. Prognostic uncertainty in
5. Cheon S, Agarwal A, Popovic M, et al. The accuracy of terminal care: Can the Karnofsky index help? Lancet.
clinicians’ predictions of survival in advanced cancer: 1985;1(8439):1204-1206.
A review. Ann Palliat Med. 2016;5(1):22-29. doi: 10.1016/s0140-6736(85)92876-4
doi: 10.3978/j.issn.2224-5820.2015.08.04
16. Kim YJ, Hui D, Zhang Y, et al. Differences in performance
6. Stone P, Buckle P, Dolan R, et al. Prognostic evaluation status assessment among palliative care specialists,
in patients with advanced cancer in the last months nurses, and medical oncologists. J Pain Symptom Manage.
of life: ESMO clinical practice guideline. ESMO Open. 2015;49(6):1050-1058.e2.
2023;8(2):101195. doi: 10.1016/j.jpainsymman.2014.10.015
doi: 10.1016/j.esmoop.2023.101195
17. Sorensen JB, Klee M, Palshof T, Hansen HH. Performance
7. Simmons CPL, McMillan DC, McWilliams K, et al. Prognostic status assessment in cancer patients. An inter-observer
tools in patients with advanced cancer: A systematic review. variability study. Br J Cancer. 1993;67(4):773-775.
J Pain Symptom Manage. 2017;53(5):962-970.e10.
doi: 10.1038/bjc.1993.140
doi: 10.1016/j.jpainsymman.2016.12.330
18. McMillan DC. The systemic inflammation-based Glasgow
8. Seow H, Barbera L, Sutradhar R, et al. Trajectory of prognostic score: A decade of experience in patients with

Volume 4 Issue 3 (2025) 54 doi: 10.36922/td.8576